Trial Profile
A retrospective chart review study evaluating rheumatoid arthritis flare rates before and after dose tapering with adalimumab (ADA) or etanercept in rheumatoid arthritis patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TAPER
- 17 Aug 2016 New trial record